Brookfield Corp’s Thermo Fisher Scientific TMO Stock Holding History

Brookfield Corp’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,213	Closed	-$633K	–	492
2023 Q2	$633K	Sell	1,213 -560	-32%	-$302K	﹤0.01%	486
2023 Q1	$1.02M	Buy	+1,773	New	+$999K	﹤0.01%	497
2022 Q4	–	Sell	-30,046	Closed	-$15.2M	–	741
2022 Q3	$15.2M	Buy	30,046 +11,345	+61%	+$6.35M	0.06%	113
2022 Q2	$10.2M	Buy	18,701 +10,843	+138%	+$5.97M	0.04%	145
2022 Q1	$4.64M	Buy	7,858 +1,731	+28%	+$994K	0.02%	278
2021 Q4	$4.09M	Buy	+6,127	New	+$3.83M	0.02%	245
2021 Q3	–	Sell	-8,934	Closed	-$4.51M	–	627
2021 Q2	$4.51M	Buy	+8,934	New	+$4.22M	0.02%	234
2021 Q1	–	Sell	-3,302	Closed	-$1.54M	–	566
2020 Q4	$1.54M	Sell	3,302 -6,179	-65%	-$2.9M	0.01%	326
2020 Q3	$4.19M	Sell	9,481 -7,022	-43%	-$2.9M	0.02%	159
2020 Q2	$5.98M	Buy	+16,503	New	+$5.53M	0.03%	126

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Brookfield Corp's TMO Position: Q3 2023 in Review

Brookfield Corp sold out of Thermo Fisher Scientific (TMO) in Q3 2023, closing a stake of 1,213 shares — an estimated $633K sold.

Brookfield Corp first reported a position in TMO in Q2 2020 and held it in 10 quarters. The position peaked at $15.2M in Q3 2022. 2,366 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

Brookfield Corp reported no remaining Thermo Fisher Scientific position as of Q3 2023 after selling out during the quarter.
Brookfield Corp sold 1,213 Thermo Fisher Scientific shares in Q3 2023, an estimated $633K.
Brookfield Corp first reported a position in Thermo Fisher Scientific in Q2 2020 and held it in 10 quarters.
Brookfield Corp's Thermo Fisher Scientific position peaked at $15.2M in Q3 2022.
2,366 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.